Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above — Stella
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(8 sites) China
Beijing Chest Hospital, Beijing, Beijing Municipality Changsha Center Hospital, Hunan, Changsha LiuZhou People's Hospital, Liuchow, Guangxi The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan Wuhan Pulmonary Hospital, Wuhan, Hubei Wuhan Central Hospital, Wuhan, Hubei Yichang Central People's Hospital, Yichang, Hubei Public health clinical center of chengdu, Chengdu, Sichuan
Key details Sponsor
Chengdu CoenBiotech Co., Ltd
Collaborators
Beijing Chest Hospital, Capital Medical University, Wuhan Pulmonary Hospital
Enrollment target
~1,784 participants
Primary completion
May 2026
Age range
3 Years and older
Last updated September 2025